President Trump's nominee to lead the Food and Drug Administration, Dr. Heidi Overton, could force a long-delayed reckoning over the safety of the abortion drug mifepristone, but she first faces resistance from both parties in the Senate. John Mize, CEO of Americans United for Life, told Fox News Digital that Overton would bring "objectivity" to […] The post Trump's FDA pick Heidi Overton faces confirmation fight as pro-life leaders eye mifepristone crackdown appeared first on American Almanac .
President Trump's nominee to lead the Food and Drug Administration, Dr. Heidi Overton, could force a long-delayed reckoning over the safety of the abortion drug mifepristone, but she first faces resistance from both parties in the Senate. John Mize, CEO of Americans United for Life, told Fox News Digital that Overton would bring "objectivity" to the FDA's handling of mifepristone, the chemical abortion drug that now accounts for roughly two-thirds of all clinician-provided abortions in the United States. Mize said he has spoken with Overton five or six times and believes she understands the risks the drug poses to women, particularly under the current rules that allow it to be prescribed after a telehealth visit and shipped by mail…Open
MS NOW medical contributor Dr. Vin Gupta joins Morning Joe to discuss President Donald Trump’s pick to lead the Food and Drug Administration, Dr. Heidi Overton. Overton, a White House aide and deputy director of the Domestic Policy Council, is a staunch ally of HHS Secretary Robert F. Kennedy Jr. and his “Make America Healthy Again” agenda. Dr. Gupta sounds the alarm over Overton’s “dangerous views" on public health, citing her criticism of abortion pills.
Dr. Heidi Overton is currently working as a White House policy aide. If confirmed, she would lead an agency of 18,000 staffers who study and regulate food, drugs, medical devices, tobacco and more.
Dr. Richard Besser, Former Acting Director of the CDC, explains the role the FDA plays in things like vaccine approval and how Trump's new pick to run the agency, Dr. Heidi Overton, will be involved in setting the nation's healthcare agenda. #FDA #CDC #Trump #vaccine #health #HeidiOverton
President Donald Trump announced that he is nominating Dr. Heidi Overton, his deputy assistant for domestic policy, to serve as the next commissioner of the Food and Drug Administration (FDA). LiveNOW’s Mike Pache spoke about Dr. Overton’s experience, and what the reaction to her pick has been, with Liz Whyte from The Wall Street Journal.
President Trump has decided to nominate White House aide Heidi Overton to lead the Food and Drug Administration, according to a senior administration official. Why it matters: The agency was left in turmoil after the exit of former commissioner Marty Makary earlier this year, threatening the stability of U.S. drug development. Between the lines: Overton, currently deputy director of the White House Domestic Policy Council, was one of several candidates that the White House had been considering for weeks. - Bloomberg first reported that she was the president's choice. The intrigue: Overton appeared at last week's Oval Office signing of an executive order calling for an overhaul of the childhood vaccine schedule, including slimming down…
